Biological Evaluation of Naproxen-Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors
The use of peptide−drug conjugates is emerging as a powerful strategy for targeted drug delivery. Previously, we have found that peptides conjugated to a non-steroidal anti-inflammatory drug (NSAID), more specifically naproxen−dehydrodipeptide conjugates, readily form nanostructured fibrilar supramo...
Saved in:
Main Authors: | Rute Moreira (Author), Peter J. Jervis (Author), André Carvalho (Author), Paula M. T. Ferreira (Author), José A. Martins (Author), Patrícia Valentão (Author), Paula B. Andrade (Author), David M. Pereira (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro Evaluation of Pharmacokinetic Properties of Selected Dual COX-2 and 5-LOX Inhibitors
by: Jelena Bošković, et al.
Published: (2024) -
Synthesis, Evaluation of Enzyme Inhibition and Redox Properties of Potential Dual COX-2 and 5-LOX Inhibitors
by: Jelena Bošković, et al.
Published: (2023) -
Evaluation of Anticonvulsant Activity of Dual COX-2/5-LOX Inhibitor Darbufelon and Its Novel Analogues
by: Mariia Mishchenko, et al.
Published: (2021) -
Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof
by: Mostafa M. M. El-Miligy, et al.
Published: (2024) -
Towards safer anti-inflammatory therapy: synthesis of new thymol-pyrazole hybrids as dual COX-2/5-LOX inhibitors
by: Mostafa M. M. El-Miligy, et al.
Published: (2023)